Rating History for PhaseBio Pharmaceuticals Inc. (PHAS) by TD Cowen

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/24/2022 Phil Nadeau Downgrade Hold
(Buy)
N/A
(N/A)
0.20
(0.07)
-65% Details